As of Mar 28
| +0.49 / +0.25%|
The 3 analysts offering 12-month price forecasts for Bio Rad Laboratories Inc have a median target of 220.00, with a high estimate of 250.00 and a low estimate of 210.00. The median estimate represents a +9.93% increase from the last price of 200.13.
The current consensus among 3 polled investment analysts is to Buy stock in Bio Rad Laboratories Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.